
Moderna (MRNA) Stock Up 23% on Positive Data for Its Coronavirus Vaccine Candidate
Moderna said its experimental coronavirus vaccine demonstrated immune responses in some of the healthy volunteers who were vaccinated in a clinical study. MRNA stock is up.